{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:31:43Z","timestamp":1787635903649,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To compare the efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism (DVT) in lower extremities after total hip arthroplasty (THA) and total knee arthroplasty (TKA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 592 patients were enrolled in the study. Clinical data of patients who underwent total hip arthroplasty (THA) and total knee arthroplasty (TKA) in our hospital from December 2021 to September 2022 were retrospectively collected, which mainly included patients\u2019 general information, surgery-related information, and DVT-related information. The patients were categorized into the nadroparin group(<jats:italic>n<\/jats:italic>\u2009=\u2009278) and the fondaparinux sodium group(<jats:italic>n<\/jats:italic>\u2009=\u2009314) according to the types of anticoagulants used. Anticoagulant therapy began 12\u201324\u00a0h after operation and continued until discharge. DVT prevalence between two groups was compared. The Statistical Package for Social Sciences (SPSS) software version 25 (SPSS, Armonk, NY, USA) was used for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of DVT in the nadroparin group and the fondaparinux sodium group was 8.3% (23\/278) and 15.0% (47\/314), respectively(<jats:italic>p<\/jats:italic>\u2009=\u20090.012). Statistical analysis showed that nadroparin group showed a lower prevalence of thrombosis than fondaparinux group (OR\u2009=\u20091.952, <jats:italic>P<\/jats:italic>\u2009=\u20090.012). Subgroup analyses showed that nadroparin group had a lower prevalence of DVT than fondaparinux group in some special patients groups such as female patients (OR\u2009=\u20092.258, <jats:italic>P<\/jats:italic>\u2009=\u20090.007), patients who are 65\u201379 years old (OR\u2009=\u20092.796, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), patients with hypertension (OR\u2009=\u20092.237, <jats:italic>P<\/jats:italic>\u2009=\u20090.042), patients who underwent TKA (OR\u2009=\u20092.091, <jats:italic>P<\/jats:italic>\u2009=\u20090.011), and patients who underwent combined spinal-epidural anesthesia (OR\u2009=\u20092.490, <jats:italic>P<\/jats:italic>\u2009=\u20090.003) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Nadroparin may have an advantage over fondaparinux sodium in preventing DVT in lower extremities after THA and TKA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-024-02440-0","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:01:48Z","timestamp":1716012108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanle","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"2440_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398:64\u201377.","journal-title":"Lancet"},{"key":"2440_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1757-7861.2010.00068.x","volume":"2","author":"Chinese Orthopaedic Association","year":"2010","unstructured":"Chinese Orthopaedic Association. Prevention of venous thromboembolism after major orthopaedic surgery. Orthop Surg. 2010;2:81\u20135.","journal-title":"Orthop Surg"},{"key":"2440_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2146\/ajhp060115","volume":"64","author":"HT Yu","year":"2007","unstructured":"Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals\u2019 compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64:69\u201376.","journal-title":"Am J Health Syst Pharm"},{"key":"2440_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","volume":"12","author":"JA Heit","year":"2015","unstructured":"Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464\u201374.","journal-title":"Nat Rev Cardiol"},{"key":"2440_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.301.10.1063","volume":"301","author":"MB Streiff","year":"2009","unstructured":"Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. JAMA. 2009;301:1063\u20135.","journal-title":"JAMA"},{"key":"2440_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1302\/2058-5241.3.170018","volume":"3","author":"DA Flevas","year":"2018","unstructured":"Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev. 2018;3:136\u201348.","journal-title":"EFORT Open Rev"},{"key":"2440_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1503\/cjs.007310","volume":"54","author":"WD Fisher","year":"2011","unstructured":"Fisher WD. Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. Can J Surg. 2011;54:344\u201351.","journal-title":"Can J Surg"},{"key":"2440_CR8","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s40265-020-01413-w","volume":"80","author":"N van Oosterom","year":"2020","unstructured":"van Oosterom N, Barras M, Bird R, Nusem I, Cottrell N. A Narrative Review of Aspirin Resistance in VTE prophylaxis for orthopaedic surgery. Drugs. 2020;80:1889\u201399.","journal-title":"Drugs"},{"key":"2440_CR9","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/cc11241","volume":"16","author":"S Thirugnanam","year":"2012","unstructured":"Thirugnanam S, Pinto R, Cook DJ, Geerts WH, Fowler RA. Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review. Crit Care. 2012;16:R43.","journal-title":"Crit Care"},{"key":"2440_CR10","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Di Nisio","year":"2016","unstructured":"Di Nisio M, van Es N, B\u00fcller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388:3060\u201373.","journal-title":"Lancet"},{"key":"2440_CR11","doi-asserted-by":"publisher","first-page":"eS24","DOI":"10.1378\/chest.11-2291","volume":"141","author":"DA Garcia","year":"2012","unstructured":"Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:eS24\u201343.","journal-title":"Chest"},{"key":"2440_CR12","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa011099","volume":"345","author":"KA Bauer","year":"2001","unstructured":"Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Steering Committee of the Pentasaccharide in major knee surgery study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305\u201310.","journal-title":"N Engl J Med"},{"key":"2440_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)08652-X","volume":"359","author":"MR Lassen","year":"2002","unstructured":"Lassen MR, Bauer KA, Eriksson BI, Turpie AG, European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002;359:1715\u201320.","journal-title":"Lancet"},{"key":"2440_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12893-022-01652-6","volume":"22","author":"D Fu","year":"2022","unstructured":"Fu D, Li L, Li Y, Liu X, Chen H, Wu N, et al. Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study. BMC Surg. 2022;22:243.","journal-title":"BMC Surg"},{"key":"2440_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.thromres.2018.04.001","volume":"166","author":"J Song","year":"2018","unstructured":"Song J, Xuan L, Wu W, Shen Y, Tan L, Zhong M. Fondaparinux versus nadroparin for thromboprophylaxis following minimally invasive esophagectomy: a randomized controlled trial. Thromb Res. 2018;166:22\u20137.","journal-title":"Thromb Res"},{"key":"2440_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rcl.2004.01.001","volume":"42","author":"JD Fraser","year":"2004","unstructured":"Fraser JD, Anderson DR. Venous protocols, techniques, and interpretations of the upper and lower extremities. Radiol Clin North Am. 2004;42:279\u201396.","journal-title":"Radiol Clin North Am"},{"key":"2440_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1160\/TH14-06-0530","volume":"113","author":"M Righini","year":"2015","unstructured":"Righini M, Le Gal G, Bounameaux H. Venous thromboembolism diagnosis: unresolved issues. Thromb Haemost. 2015;113:1184\u201392.","journal-title":"Thromb Haemost"},{"key":"2440_CR18","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJMoa011100","volume":"345","author":"BI Eriksson","year":"2001","unstructured":"Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Steering Committee of the Pentasaccharide in hip-fracture surgery study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345:1298\u2013304.","journal-title":"N Engl J Med"},{"key":"2440_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43019-021-00100-8","volume":"33","author":"S Thiengwittayaporn","year":"2021","unstructured":"Thiengwittayaporn S, Budhiparama N, Tanavalee C, Tantavisut S, Sorial RM, Li C, et al. Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: part 3. Pharmacological venous thromboembolism prophylaxis. Knee Surg Relat Res. 2021;33:24.","journal-title":"Knee Surg Relat Res"},{"key":"2440_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/01.mcp.0000174233.55348.16","volume":"11","author":"D Bergqvist","year":"2005","unstructured":"Bergqvist D. Low-molecular-weight heparin for the prevention of postoperative venous thromboembolism after abdominal surgery: a review. Curr Opin Pulm Med. 2005;11:392\u20137.","journal-title":"Curr Opin Pulm Med"},{"key":"2440_CR21","doi-asserted-by":"publisher","first-page":"eS278","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Y Falck-Ytter","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:eS278\u2013325.","journal-title":"Chest"},{"key":"2440_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/VHRM.S150474","volume":"14","author":"A Senay","year":"2018","unstructured":"Senay A, Trottier M, Delisle J, Banica A, Benoit B, Laflamme GY, et al. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada. Vasc Health Risk Manag. 2018;14:81\u20139.","journal-title":"Vasc Health Risk Manag"},{"key":"2440_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/jama.2011.2029","volume":"307","author":"JM Januel","year":"2012","unstructured":"Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA. 2012;307:294\u2013303.","journal-title":"JAMA"},{"key":"2440_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jacc.2018.04.066","volume":"72","author":"SWY Law","year":"2018","unstructured":"Law SWY, Lau WCY, Wong ICK, Lip GYH, Mok MT, Siu CW, et al. Sex-based differences in outcomes of oral anticoagulation in patients with Atrial Fibrillation. J Am Coll Cardiol. 2018;72:271\u201382.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-024-02440-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T06:05:20Z","timestamp":1716012320000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-024-02440-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1186\/s12893-024-02440-0","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this retrospective study was approved by the ethics committees of the Second Affiliated Hospital of Wenzhou Medical University. And the informed consents were waived approved by the ethics committees of the Second Affiliated Hospital of Wenzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}